Market revenue in 2022 | USD 1,229.1 million |
Market revenue in 2030 | USD 2,208.4 million |
Growth rate | 7.6% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.52% in 2022. Horizon Databook has segmented the Germany molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is witnessing a significant growth in its biotechnology industry. The medical or healthcare sector, which makes use of advanced biotechnology research for development of pharmaceutical and diagnostic products or vaccines, has significantly contributed to this growth.
This can be attributed to an increase in age-associated diseases and increase in geriatric population. The expanding biotechnology industry is anticipated to boost the market for molecular biology enzymes, kits, and reagents in the country.
In addition, presence of key manufacturers and biotechnology companies such as QIAGEN, Merck KGaA, Rentschler Biotechnologie GmbH, and Milltenyi Biotech GmbH are key contributors to the market revenue in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into Germany molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account